期刊文献+

膀胱移行细胞癌组织中B7-H1和PTEN的表达及意义 被引量:3

Expression and significance of B7-H1 and PTEN in bladder transitional cell carcinoma
下载PDF
导出
摘要 目的探讨共刺激分子B7-H1和PTEN在膀胱移行细胞癌组织中的表达变化及意义。方法采用免疫组化SP法检测50例膀胱移行细胞癌及10例正常膀胱组织中的B7-H1和PTEN,分析其与膀胱移行细胞癌临床病理参数的关系及两者的相关性。结果正常膀胱组织中B7-H1不表达,膀胱移行细胞癌组织中B7-H1的阳性表达率为72%,且B7-H1的表达与肿瘤的病理分级、临床分期及复发密切相关(P<0.05);正常膀胱组织中PTEN呈阳性表达,膀胱移行细胞癌中PTEN蛋白阳性表达率为58%,随着肿瘤病理分级、临床分期的增加PTEN表达显著降低(P<0.05)。B7-H1与PTEN的表达呈明显负相关(r=-0.44,P<0.01)。结论膀胱移行细胞癌中B7-H1的高表达和PTEN的突变或缺失与肿瘤的发生发展和免疫逃逸密切相关。 Objective To investigate the expression and significance of B7-H1 and PTEN in bladder transitional cell carcinoma. Methods The expression of B7-H1 and PTEN in 50 eases of bladder transitional cell carcinoma was detected by immunohistochemieal SP method and the relationship between the expression and clinical pathological parameters of bladder transitional cell carcinoma was also analyzed. Result In normal bladder t'issue, B7-H1 was not detected. But in bladdertransitional eel/carcinoma, the positive rate of B7-H1 was 72% and B7-H1 expression was strongly associated with pathological grade, clinical stage and recurrence ( P 〈 0.05 ). In normal bladder tissue, PTEN was all detected. But in bladder transitional cell carcinoma, the positive rate of PTEN was only 58% and frI'EN expression was also associated with pathological grade and clinical stage ( P 〈 0.05 ). And BT-H1 expression had a negative correlation with PTEN ( r = - 0.44, P 〈 O. 01 ). Conclusions The high expression of B7-H1 and the loss of [rI'EN are strongly associated with neoplastic proggression and may play an important role in immune escape of bladder transitional cell carcinoma.
出处 《山东医药》 CAS 北大核心 2009年第18期20-22,共3页 Shandong Medical Journal
基金 湖北省科技攻关计划资助项目(2007AA402C60)
关键词 膀胱肿瘤 共刺激分子B7-H1 抑癌基因PTEN bladder neoplasm costimulatory molecule B7-H1 phosphatase and tensin homolog
  • 相关文献

参考文献10

  • 1Dong H, Strome SE, Salomao DR, et ah Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion [J]. Nat Med, 2002,8(8) :793-800.
  • 2Parsa AT, Waldron JS, Panner A, et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistanee in glioma [J]. Nat Med, 2007,13( 1 ) :84-88.
  • 3Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion [ J]. Nat Med, 1999,5 (12) : 1365-1369.
  • 4Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death 1 ligands on dendritic cells enhanced T cell activation and cytokine production [J]. J Immunol, 2003,170(3) :1257-1266.
  • 5Konishi J, Yamazaki K, Azuma M, et al. B7-H1 expression on non-small cell lung cancer ceils and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression [ J ]. Clin Cancer Res, 2004,10(15) :5094-5100.
  • 6Thompson RH, GiUett MD, Cheville JC, et al. Costimulatory BT- H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target [ J ]. Proc Nad Acad Sci USA, 2004,101 (49) :17174-17179.
  • 7Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J]. Science, 1997,275 (5038) : 1943-1947.
  • 8Ali IU, Schriml LM, Dean M, et al. Mutational spectra of PTEN/ MMAC1 gene: a tumor suppressor with lipid phosphatase activity [ J ]. J Natl Cancer lnst, 1999,91 (22) : 1922-1932.
  • 9Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis [J]. J Call Sci, 2001, 114 (13) : 2375-2382.
  • 10Chow LM, Baker SJ. PTEN function in normal and neoplastic growth [J]. Cancer Lett, 2006, .241(2) : 184-196.

同被引文献28

  • 1李慧娥,冷雪芹,苏秉忠.PTEN和p33/ING1在食管癌的发生及浸润转移中的作用[J].中国医疗前沿(学术版),2008,3(2):12-13. 被引量:1
  • 2Liang, Xue-Song,Zhou, Ying,Li, Chen-Zhong,Wan, Mo-Bin.Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells[J].World Journal of Gastroenterology,2010,16(5):618-624. 被引量:16
  • 3张建华,杨为民,周四维.PTEN和VEGF的表达与膀胱癌血管生成关系的研究[J].中华泌尿外科杂志,2005,26(9):598-600. 被引量:4
  • 4Zha YY,Blank C,Gajewski TF.Negative regulation of T-cell function by PD-1[J].Critical Reviews in Immunolo-gy,2004,24(4):229-237.
  • 5Sharpe,Arlene H,Wherry E,et al.The function of pro-grammed cell death 1 and its ligands in regulating autoim-munity and infection[J].Nature Immunology,2007,8(3):239-245.
  • 6Waisman A,Yogev N.B7-H1 and CD8(+)Treg:The e-nigmatic role of B7-H1 in peripheral tolerance[J].Euro-pean Journal of Immunology,2009,39(6):1448-1451.
  • 7Cai GF,Karni A,Oliveira EML,et al.PD-1 ligands,negative regulators for activation of naive,memory,and re-cently activated human CD4(+)T cells[J].Cellular Im-munology,2004,230(2):89-98.
  • 8Angela M,Aranya B,Harlyn K,et al.Upregulation ofPD-L1 on monocytes and dendritic cells by HIV-1 derivedTLR Ligands[J].AIDS,2008,22(5):655-658.
  • 9Lucas JA,Menke J,Rabacal WA,et al.Programmeddeath ligand 1 regulates a critical checkpoint for autoim-mune myocarditis and pneumonitis in MRL mice[J].TheJournal of Immunology,2008,181(4):2513-2521.
  • 10Okazaki T,Honjo T.PD-1 and PD-1 ligands:from discov-ery to clinical application[J].International Immunology,2007,19(7):813-824.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部